Radiologic and serologic features of extensive venous malformations associated with atrophy, osteoporosis, and visceral involvement: Implications for future management

Dermatologic Surgery

Volumn 34, Issue 12, 2008, Pages 1718-1725

  Redondo, Pedro ^a   Bastarrika, Gorka ^a  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; PARATHYROID HORMONE[1-34]; RISEDRONIC ACID;

ADULT; ARTICLE; BONE ATROPHY; CASE REPORT; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; OSTEOPOROSIS; PHLEBOGRAPHY; PRIORITY JOURNAL; SCLEROTHERAPY; SEROLOGY; TREATMENT PLANNING; VEIN MALFORMATION;

ABNORMALITIES, MULTIPLE; ADULT; ATROPHY; BONE AND BONES; FEMALE; HUMANS; MALE; OSTEOPOROSIS; VEINS;

EID: 57249111994     PISSN: 10760512     EISSN: 15244725     Source Type: Journal    
DOI: 10.1111/j.1524-4725.2008.34358.x     Document Type: Article

References (34)

1. Eifert S, Villavicencio JL, Kao TC, et al. Prevalence of deep venous anomalies in congenital vascular malformations of venous predominance. J Vasc Surg 2000 31 : 462 71.
2. Laor T, Burrows PE. Congenital anomalies and vascular birthmarks of the lower extremity. Magn Reson Imag Clin N Am 1998 6 : 497 519.
3. Enjolras O, Mulliken JB. Vascular malformations. In : Harper J, Oranje A, Prose N, editors. Textbook of pediatric dermatology. Oxford : Blackwell Sciences Ltd 2000. p. 975 7.
4. Enjolras O, Ciabrini D, Mazoyer E, et al. Extensive pure venous malformations in the upper or lower limb, a review of 27 cases. J Am Acad Dermatol 1997 36 : 219 25.
5. Mulliken JB, Glowacki J. Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg 1982 69 : 412 9.
6. Belov S. Classification of congenital vascular defects. Int Angiol 1990 9 : 141 6.
7. Malan E, Puglionisi A. Congental angiodysplasia of the extremities. J Cardiol Surg 1964 5 : 87 130.
8. Ly JQ, Sanders TG, San Diego JW. Hemangioma of the triceps muscle. Am J Roentgenol 2003 181 : 544.
9. Kuo P-H, Chang Y-C, Liou J-H, Lee J-M. Mediastinal cavernous haemangioma in a patient with Klippel-Trenaunay syndrome. Thorax 2003 58 : 183 4.
10. Cabrera J, Cabrera J Jr., García-Olmedo MA, Redondo P. Treatment of venous malformations with sclerosant in microfoam form. Arch Dermatol 2003 139 : 1409 16.
11. Hsu TS, Weiss RA. Foam sclerotherapy: a new era. Arch Dermatol 2003 139 : 1494 6.
12. Maari C, Frieden IJ. Klippel-Trenaunay syndrome: the importance of "geographic stains" in identifying lymphatic disease and risk of complications. J Am Acad Dermatol 2004 51 : 391 8.
13. Van Geest AJ, Veraart JC, de Haan M, Neumann HA. Bockenheimer's syndrome. J Eur Acad Dermatol Venereol 1999 12 : 165 8.
14. Mulliken J, Young AE. Vascular birthmarks: hemangiomas and malformations. Philadelphia : W.B Saunders 1988 : 203.
15. Legiehn GM, Heran MK. Classification, diagnosis, and interventional radiologic management of vascular malformations. Orthop Clin North Am 2006 37 : 435 74.
16. Puig S, Casati B, Staudenherz A, Paya K. Vascular low-flow malformations in children: current concepts for classification, diagnosis and therapy. Eur J Radiol 2005 53 : 35 45.
17. Napoli A, Fleischmann D, Chan FP, et al. Computed tomography angiography: state-of-the-art imaging using multidetector-row technology. J Comput Assist Tomogr 2004 28 (Suppl 1) : S32 45.
18. Nael K, Laub G, Finn JP. Three-dimensional contrast-enhanced MR angiography of the thoraco-abdominal vessels. Magn Reson Imag Clin N Am 2005 13 : 359 80.
19. Bastarrika G, Redondo P, Sierra A, et al. New techniques for the evaluation and therapeutic planning of patients with Klippel-Trénaunay syndrome. J Am Acad Dermatol 2007 56 : 242 9.
20. Hein KD, Mulliken JB, Kozakewich HP, et al. Venous malformations of skeletal muscle. Plast Reconstr Surg 2002 110 : 1625 35.
21. Enjolras O, Chapot R, Merland JJ. Vascular anomalies and the growth of limbs: a review. J Pediatr Orthop B 2004 13 : 349 57.
22. Boyd JB, Mulliken JB, Kaban LB, et al. Skeletal changes associated with vascular malformations. Plast Reconstr Surg 1984 76 : 789.
23. Eimori K, Ogose A, Hotta T, et al. Treatment of pathological fracture of the femur due to diffuse haemangioma in the lower limb. J Bone Jt Surg Br 2005 87 : 412 4.
24. Benchakroun M, Ouadghiri M, Berrada S, et al. Pathological fracture of the femur in a patient with a venous malformation. Rev Chir Orthop Reparatrice Appar Mot 2004 90 : 280 4.
25. Plotkin LI, Weinstein TS, Parfitt AM, et al. Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin. J Clin Invest 1999 104 : 1363 74.
26. Hodsman AB, Bauer DC, Dempster D, et al. Parathyroid hormone and teriparatide for the treatment of osteoporosis: a review of the evidence and suggested guidelines for its use. Endocr Rev 2005 26 : 688 703.
27. Schneider HJ, Lascari AD. Consumption coagulopathy in an infant with Kasabach-Merrit syndrome. Helv Paediatr Acta 1968 23 : 674 9.
28. Mazoyer E, Enjolras O, Laurian C, et al. Coagulation abnormalities associated with extensive venous malformations of the limbs: differentiation from Kasabach-Merrit síndrome. Clin Lab Haematol 2002 24 : 243 51.
29. Marler J, Fishman SJ, Kilroy SM, et al. Increased expression of urinary matrix metalloproteinases parallels the extent and activity of vascular anomalies. Pediatrics 2005 116 : 38 45.
30. Enciso JM, Hirschi KK. Understanding abnormalities in vascular specification and remodeling. Pediatrics 2005 116 : 228 30.
31. Hata K, Udagawa J, Fujiwaki R, et al. Expression of angiopoietin-1, angiopoietin-2, and Tie2 genes in normal ovary with corpus luteum and in ovarian cancer. Oncology 2002 62 : 340 8.
32. Lobov IB, Brooks PC, Lang RA. Angiopoietin-2 displays VEGF-dependent modulation of capillary structure and endothelial cell survival in vivo. Proc Natl Acad Sci U S A 2002 99 : 11205 10.
33. Hashimoto T, Lam T, Boudreau NJ, et al. Abnormal balance in the angiopoietin-tie2 system in human brain arteriovenous malformations. Circ Res 2001 89 : 111 3.
34. Ferrara N, Kerbel RS. Angiogenesis as a therapeutic target. Nature 2005 438 : 967 74.